Business description: Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows:

- hospital administration and engineering (59.2%; Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.;

- perfusion and clinical nutrition (37.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc.;

- other (3.1%).

Number of employees: 177,783

Sales by Activity: Fresenius SE & Co. KGaA

Fiscal Period: December 2021 (EUR) 2022 (EUR) 2023 (EUR) 2024 (EUR) 2025 (EUR)

Fresenius Helios

10.89B 11.72B 12.32B 12.74B 13.55B

Fresenius Kabi

7.19B 7.85B 8.01B 8.41B 8.61B

Corporate / Other

-480M -483M -386M 680M 711M

Fresenius Vamed

2.3B 2.36B 2.36B - -

Fresenius Medical Care

17.62B 19.4B - - -

Geographical breakdown of sales: Fresenius SE & Co. KGaA

Fiscal Period: December 2021 (EUR) 2022 (EUR) 2023 (EUR) 2024 (EUR) 2025 (EUR)

Europe

16.89B 17.88B 16.15B 15.66B 16.77B

North America

14.36B 16.11B 2.74B 2.7B 2.74B

Asia-Pacific

3.94B 4.14B 1.64B 1.6B 1.5B

Latin America

1.83B 2.18B 1.42B 1.4B 1.38B

Africa

501M 534M 356M 156M 163M

Executive Committee: Fresenius SE & Co. KGaA

Manager TitleAgeSince
Chief Executive Officer 57 30/09/2022
Director of Finance/CFO 46 31/08/2022
Compliance Officer 50 -
Corporate Secretary - -
Investor Relations Contact - 31/12/2014

Composition of the Board of Directors: Fresenius SE & Co. KGaA

Director TitleAgeSince
Director/Board Member 71 19/05/2015
Director/Board Member 65 12/05/2016
Director/Board Member 52 31/12/2015
Director/Board Member 67 31/08/2018
Chairman 71 20/05/2021
Director/Board Member 53 30/04/2020
Director/Board Member 65 08/02/2022
Director/Board Member 64 12/05/2022
Director/Board Member 58 29/11/2023
Director/Board Member 42 22/05/2025

Shareholders: Fresenius SE & Co. KGaA

NameStocks%Valuation
Else Kröner-Fresenius-Stiftung
27.11 %
152,679,509 27.11 % 6 462 M €
Fidelity Management & Research Co. LLC
2.772 %
15,614,974 2.772 % 661 M €
FMR Investment Management (UK) Ltd.
0.5111 %
2,878,540 0.5111 % 122 M €
AllianceBernstein Investments Taiwan Ltd.
0.4458 %
2,511,079 0.4458 % 106 M €
White Creek Capital LLP
0.2554 %
1,438,288 0.2554 % 61 M €
NameStocks%Valuation
BG Fund Management Luxembourg SA
-
1,620 - - €
NameStocks%Valuation
Yousif Capital Management LLC
0.001051 %
23,681 0.001051 % 250 569 €
RhumbLine Advisers LP
0.000407 %
9,174 0.000407 % 97 070 €
GAMMA Investing LLC
0.000207 %
4,670 0.000207 % 49 413 €
Salomon & Ludwin LLC
0.000012 %
270 0.000012 % 2 857 €
Hantz Financial Services, Inc.
0.000002 %
52 0.000002 % 550 €

Holdings: Fresenius SE & Co. KGaA

NameStocks%Valuation
81,625,39030.39% 3 542 M $

Company details: Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA

Else-Kröner-Strasse 1

61352, Bad Homburg

+49 6172 6080

http://www.fresenius.de
address Fresenius SE & Co. KGaA(FRE)

Group companies: Fresenius SE & Co. KGaA

NameCategory and Sector
Life/Health Insurance
Life/Health Insurance
Taiwan Fresenius Kabi Co., Ltd.
Taiwan Fresenius Kabi Co., Ltd.
Miscellaneous Commercial Services

Other Healthcare Facilities & Services

Change 5-day change 1-year change 3-year change Capi.($)
-0.21%+4.30%-11.85%+49.92% 25.39B
-0.54%+3.25%+48.00%+47.98% 128B
+1.66%+5.66%+7.47%+36.55% 86.51B
-0.77%-1.85%+10.26%+44.84% 22.38B
-0.18%-2.42%+0.27%+12.98% 21.73B
0.00%+3.40%-16.21%-20.59% 20.4B
+2.00%+9.99%+11.41%+133.30% 15.43B
+1.69%+3.12%-3.21%+3.46% 14.71B
-0.73%+5.39%+51.53%+113.97% 13.47B
+0.81%+6.21%-17.09%-5.59% 12.68B
Average +0.33%+5.35%+8.06%+41.68% 36.12B
Weighted average by Cap. +0.26%+5.16%+19.44%+41.62%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
38.85EUR
Average target price
54.79EUR
Spread / Average Target
+41.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FRE Stock
  4. Company Fresenius SE & Co. KGaA
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!